Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Harding

Showing results (301-310 of 380) with videos related to

Pageof 38
Sort By:
Dalton Transactions (Cambridge, England : 2003)|December 22, 2009
Coumarin-based luminescent ligand that forms helicates with dicationic metal ionsSam J Bullock, Cara E Felton, Rebecca V Fennessy, et al.
The British Journal of Ophthalmology|December 17, 2008
Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degenerationS Murjaneh, M García-Fiñana, S Mahmood, et al.
The Journal of Biological Chemistry|June 14, 2008
Novel function of PERK as a mediator of force-induced apoptosisBaldwin C Mak, Qin Wang, Carol Laschinger, et al.
The Journal of Trauma and Acute Care Surgery|May 11, 2026
Surgical care at sea: A retrospective review of the maritime surgical and quality improvement databaseSophia M V Schermerhorn, Caleb F Adkins, Lindsey M Sawczuk, et al.
The Journal of Biological Chemistry|January 18, 2011
Arginine deficiency causes runting in the suckling period by selectively activating the stress kinase GCN2Vincent Marion, Selvakumari Sankaranarayanan, Chiel de Theije, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomesSimon P Harding, Keith Tomlin, Barnaby C Reeves, et al.
Molecular and Cellular Biology|January 20, 2004
Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress responseHao-Yuan Jiang, Sheree A Wek, Barbara C McGrath, et al.
Science (New York, N.Y.)|February 12, 2005
A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stressMichael Boyce, Kevin F Bryant, Céline Jousse, et al.
BMJ Open|August 1, 2014
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trialHelen A Dakin, Sarah Wordsworth, Chris A Rogers, et al.
Brain : a Journal of Neurology|March 1, 2014
Cerebral malaria in children: using the retina to study the brainIan J C MacCormick, Nicholas A V Beare, Terrie E Taylor, et al.
Pageof 38

Showing results (301-310 of 380) with videos related to

Sort By:
Pageof 38
Dalton Transactions (Cambridge, England : 2003)|December 22, 2009
Coumarin-based luminescent ligand that forms helicates with dicationic metal ionsSam J Bullock, Cara E Felton, Rebecca V Fennessy, et al.
The British Journal of Ophthalmology|December 17, 2008
Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degenerationS Murjaneh, M García-Fiñana, S Mahmood, et al.
The Journal of Biological Chemistry|June 14, 2008
Novel function of PERK as a mediator of force-induced apoptosisBaldwin C Mak, Qin Wang, Carol Laschinger, et al.
The Journal of Trauma and Acute Care Surgery|May 11, 2026
Surgical care at sea: A retrospective review of the maritime surgical and quality improvement databaseSophia M V Schermerhorn, Caleb F Adkins, Lindsey M Sawczuk, et al.
The Journal of Biological Chemistry|January 18, 2011
Arginine deficiency causes runting in the suckling period by selectively activating the stress kinase GCN2Vincent Marion, Selvakumari Sankaranarayanan, Chiel de Theije, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomesSimon P Harding, Keith Tomlin, Barnaby C Reeves, et al.
Molecular and Cellular Biology|January 20, 2004
Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress responseHao-Yuan Jiang, Sheree A Wek, Barbara C McGrath, et al.
Science (New York, N.Y.)|February 12, 2005
A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stressMichael Boyce, Kevin F Bryant, Céline Jousse, et al.
BMJ Open|August 1, 2014
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trialHelen A Dakin, Sarah Wordsworth, Chris A Rogers, et al.
Brain : a Journal of Neurology|March 1, 2014
Cerebral malaria in children: using the retina to study the brainIan J C MacCormick, Nicholas A V Beare, Terrie E Taylor, et al.
Pageof 38